株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の全身麻酔薬市場:分子タイプ、地域別 - 市場規模、シェア、見通し、および機会分析(2019年~2027年)

General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

発行 Coherent Market Insights 商品コード 920730
出版日 ページ情報 英文 190 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.49円で換算しております。
世界の全身麻酔薬市場:分子タイプ、地域別 - 市場規模、シェア、見通し、および機会分析(2019年~2027年) General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日: 2019年12月26日 ページ情報: 英文 190 Pages
概要

当レポートは世界の全身麻酔薬市場について調査しており、市場機会、製品の発売、影響分析、成長および阻害要因、分子タイプ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査目的・前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の範囲

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 分子タイプ別
    • 地域別
    • Coherent Opportunity Map (COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 主なハイライト
  • 製品発売
  • 規制シナリオ
  • PEST分析
  • 合併と買収

第4章 市場分析:分子タイプ別

  • イントロダクション
  • プロポフォール
  • セボフルラン
  • デクスメデトミジン
  • デスフルラン
  • レミフェンタニル
  • ミダゾラム
  • その他

第5章 市場分析:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第6章 競合情勢

  • 企業プロファイル
    • Baxter International Inc.
    • AstraZeneca
    • AbbVie Inc.
    • B. Braun Melsungen AG
    • Fresenius SE & Co. KGaA
    • Hospira Inc.

第7章 セクション

  • 参照資料
  • 調査方法
  • 当社について
目次

Title:
General Anesthesia Drugs Market, By Molecule Type (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

General anesthesia is a therapeutically induced condition of unconsciousness; that is, loss of protective reflexes, which results from the use of one or multiple general anesthetic agents. The drug is administered to allow performing the medical procedures which are unbearably painful for the patient. A range of medicines can be administered, the overall aim of which is to ensure unconsciousness, analgesia, and loss of reflexes of the ANS or autonomic nervous system. In some cases, general anesthetic drugs are used for paralyzing the skeletal muscles.

Key features of the study::

  • This report provides in-depth analysis of the General Anesthesia Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global General Anesthesia Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global General Anesthesia Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global General Anesthesia Drugs market

Detailed Segmentation::

  • General Anesthesia Drugs Market, By Molecule Type:
    • Propofol
    • Sevoflurane
    • Dexmedetomidine
    • Desflurane
    • Remifentanil
    • Midazolam
    • Others
  • General Anesthesia Drugs Market, By Region:
    • North America
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Baxter International Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • AstraZeneca
    • AbbVie Inc.
    • B. Braun Melsungen AG
    • Fresenius SE & Co. KGaA
    • Hospira Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Molecule Type
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • Regulatory Scenario
  • PEST Analysis
  • Mergers and Acquisitions

4. Global General Anesthesia Drugs Market, By Molecule Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Propofol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Keratolytics
    • Moisturizers
    • Retinoids
    • SunScreens
    • Hair Removals
  • Sevoflurane
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Dexmedetomidine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Desflurane
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Remifentanil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Midazolam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. Global General Anesthesia Drugs Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

6. Competitive Landscape

  • Company Profiles
    • Baxter International Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • B. Braun Melsungen AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fresenius SE & Co. KGaA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hospira Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact